News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
744,400 Results
Type
Article (48200)
Company Profile (351)
Press Release (695849)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (214004)
Career Advice (2188)
Deals (36814)
Drug Delivery (105)
Drug Development (84176)
Employer Resources (177)
FDA (16997)
Job Trends (15496)
News (360832)
Policy (33926)
Tag
Academia (2807)
Academic (1)
Accelerated approval (9)
Adcomms (26)
Allergies (101)
Alliances (53345)
ALS (111)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (176)
Approvals (16972)
Artificial intelligence (345)
Autoimmune disease (32)
Automation (18)
Bankruptcy (372)
Best Places to Work (12028)
BIOSECURE Act (20)
Biosimilars (124)
Biotechnology (254)
Bladder cancer (94)
Brain cancer (38)
Breast cancer (374)
Cancer (2937)
Cardiovascular disease (226)
Career advice (1831)
Career pathing (32)
CAR-T (195)
CDC (32)
Cell therapy (522)
Cervical cancer (22)
Clinical research (68865)
Collaboration (1059)
Company closure (3)
Compensation (686)
Complete response letters (23)
COVID-19 (2769)
CRISPR (65)
C-suite (323)
Cystic fibrosis (114)
Data (2974)
Decentralized trials (2)
Denatured (34)
Depression (61)
Diabetes (350)
Diagnostics (6764)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (149)
Drug pricing (131)
Drug shortages (29)
Duchenne muscular dystrophy (126)
Earnings (89574)
Editorial (44)
Employer branding (22)
Employer resources (154)
Events (120134)
Executive appointments (886)
FDA (18646)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (964)
Gene editing (145)
Generative AI (30)
Gene therapy (401)
GLP-1 (829)
Government (4677)
Grass and pollen (5)
Guidances (180)
Healthcare (19761)
Huntington's disease (31)
IgA nephropathy (40)
Immunology and inflammation (160)
Immuno-oncology (8)
Indications (40)
Infectious disease (2943)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (63)
Intellectual property (119)
Interviews (338)
IPO (17075)
IRA (47)
Job creations (3880)
Job search strategy (1550)
Kidney cancer (14)
Labor market (52)
Layoffs (526)
Leadership (20)
Legal (8216)
Liver cancer (80)
Lung cancer (413)
Lymphoma (209)
Machine learning (10)
Management (62)
Manufacturing (394)
MASH (89)
Medical device (14231)
Medtech (14236)
Mergers & acquisitions (20462)
Metabolic disorders (869)
Multiple sclerosis (100)
NASH (17)
Neurodegenerative disease (123)
Neuropsychiatric disorders (33)
Neuroscience (2187)
NextGen: Class of 2025 (6947)
Non-profit (4699)
Now hiring (47)
Obesity (439)
Opinion (240)
Ovarian cancer (101)
Pain (110)
Pancreatic cancer (120)
Parkinson's disease (192)
Partnered (22)
Patents (302)
Patient recruitment (157)
Peanut (53)
People (60445)
Pharmaceutical (72)
Pharmacy benefit managers (21)
Phase I (21743)
Phase II (30273)
Phase III (22411)
Pipeline (1636)
Policy (204)
Postmarket research (2638)
Preclinical (9386)
Press Release (71)
Prostate cancer (144)
Psychedelics (36)
Radiopharmaceuticals (275)
Rare diseases (479)
Real estate (6297)
Recruiting (67)
Regulatory (23537)
Reports (50)
Research institute (2545)
Resumes & cover letters (387)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (84)
Series A (163)
Series B (110)
Service/supplier (15)
Sickle cell disease (65)
Special edition (20)
Spinal muscular atrophy (156)
Sponsored (33)
Startups (3920)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (58)
The Weekly (55)
Vaccines (820)
Venture capital (54)
Weight loss (277)
Women's health (46)
Worklife (17)
Date
Today (2)
Last 7 days (330)
Last 30 days (2071)
Last 365 days (32389)
2025 (16892)
2024 (36716)
2023 (41609)
2022 (52878)
2021 (57494)
2020 (56091)
2019 (48936)
2018 (36877)
2017 (34015)
2016 (33707)
2015 (39879)
2014 (33488)
2013 (28735)
2012 (30885)
2011 (31466)
2010 (29394)
Location
Africa (787)
Alabama (64)
Alaska (7)
Arizona (253)
Arkansas (14)
Asia (41721)
Australia (6972)
California (7542)
Canada (2337)
China (697)
Colorado (323)
Connecticut (333)
Delaware (197)
Europe (92436)
Florida (1117)
Georgia (257)
Hawaii (1)
Idaho (62)
Illinois (659)
India (28)
Indiana (365)
Iowa (17)
Japan (230)
Kansas (113)
Kentucky (29)
Louisiana (16)
Maine (64)
Maryland (1040)
Massachusetts (5703)
Michigan (267)
Minnesota (460)
Mississippi (3)
Missouri (98)
Montana (31)
Nebraska (25)
Nevada (81)
New Hampshire (72)
New Jersey (2088)
New Mexico (30)
New York (2112)
North Carolina (1128)
North Dakota (10)
Northern California (3280)
Ohio (239)
Oklahoma (17)
Oregon (40)
Pennsylvania (1632)
Puerto Rico (18)
Rhode Island (37)
South America (1176)
South Carolina (34)
South Dakota (1)
Southern California (2812)
Tennessee (126)
Texas (1133)
United States (28130)
Utah (225)
Virginia (188)
Washington D.C. (73)
Washington State (647)
West Virginia (4)
Wisconsin (69)
744,400 Results for "molecular targeting technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
June 17, 2025
·
8 min read
Press Releases
Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development
June 4, 2025
·
4 min read
Collaboration
Genentech Bets Again on Orionis With Potential $2B+ in Crowded Molecular Glue Space
Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to use in cancer, immunology and other applications.
May 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
June 23, 2025
·
8 min read
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and Novartis.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Rapafusyn Selected to Join the Roche Accelerator to Advance Discovery and Development of Transformational Medicines for Difficult-to-Drug Targets Using Non-Degrading Molecular Glues
May 27, 2025
·
1 min read
Lone Star Bio
Molecular Templates, Inc. Provides Interim Update
Molecular Templates, Inc. today provided an update on its clinical-stage programs.
June 3, 2024
·
7 min read
Press Releases
Verasonics Announces Partnership With PhotoSound Technologies, Inc.
June 24, 2025
·
3 min read
Pharm Country
Molecular Targeting Technologies, Inc. to Present EvaThera, Long-Acting Peptide Receptor Radionuclide Therapy Platform, at BioFuture™ 2023
Molecular Targeting Technologies, Inc., is presenting at BioFuture 2023 on Thursday 2:45 PM, Oct 5th, at Lotte New York Palace hotel.
October 5, 2023
·
2 min read
Pharm Country
Molecular Targeting Technologies, Inc. and Molecular Theranostics Center of Singapore Receive HSA Approval for Clinical Trial Authorization for EBTATE® in Nasopharyngeal Cancer
Molecular Targeting Technologies, Inc., and its wholly owned subsidiary, Molecular Theranostic Center of Singapore, announced the approval of a Clinical Trial Authorization application by the Health Sciences Authority of Singapore.
August 2, 2023
·
2 min read
1 of 74,440
Next
